🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: CT-322 may stop the growth of glioblastoma multiforme by blockin...
Status
Unknown
Location
University of California, San Diego
Start Date
2007-10
Trial ID
NCT00562419
Treatments Being Tested
Rationale: In light of the demonstrated activity of anti-angiogenesis agen...
Status
Unknown
Location
University of Arkansas for Medical Sciences
Start Date
2008-10
Trial ID
NCT00768911
Treatments Being Tested
The purpose of this study is to determine the efficacy of CT-322 comparativ...
Status
Terminated
Location
Acrc/Arizona Clinical Research Center, Inc.
Start Date
2009-06
Trial ID
NCT00850577
Treatments Being Tested
The purpose of this study is to determine the efficacy of CT-322 comparativ...
Status
Completed
Location
Acrc/Arizona Clinical Research Center, Inc.
Start Date
2009-10
Trial ID
NCT00851045
The purpose of this clinical study is to evaluate the safety and tolerabili...
Status
Withdrawn
Location
Local Institution
Start Date
2013-11
Trial ID
NCT01146171
Treatments Being Tested
RATIONALE: CT-322 may stop the growth of solid tumors or non-Hodgkin's lymp...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2006-08
Trial ID
NCT00374179
Treatments Being Tested